We provide a comprehensive suite of solutions to address the capital needs of GPs and entrepreneurs.
The firm proactively collaborates with founders, fund managers, and LPs across the venture lifecycle—from inception through exit. With investments in over 425 venture funds and 325 companies, we take a data-driven approach to investing in leading venture funds and companies through both primary and secondary transactions.
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others.
Secondary Investment
Through our secondary investments, we provide access to leading, late-stage venture-backed companies while aiming to deliver faster liquidity and mitigate downside risk for our limited partners.
Primary Commitments
Through our secondary investments, we provide access to leading, late-stage venture-backed companies while aiming to deliver faster liquidity and mitigate downside risk for our limited partners.
Direct Investments
Through our secondary investments, we provide access to leading, late-stage venture-backed companies while aiming to deliver faster liquidity and mitigate downside risk for our limited partners.
Tech Buyout Investments
Through our secondary investments, we provide access to leading, late-stage venture-backed companies while aiming to deliver faster liquidity and mitigate downside risk for our limited partners.
Our Approach
We provide liquidity to early employees, founders, angel investors, tail-end venture funds, corporate venture arms, LPs, and other holders of venture assets. Our longstanding history in the venture secondary market has made us a trusted partner by many, allowing us to diligence and access high quality investments and efficiently execute transactions.
We acquire limited partnership interests in venture capital funds, facilitate special situation investments, and directly purchase shares in mature and pre-IPO businesses through secondary transactions. Our flexibility and creativity enables us to structure a solution for the most straightforward to the most complicated parameters.
A unified approach for access to the best complete venture lifecycle with comple mentary risk, reward, and liquidity profiles.
Through our secondary investments, we provide access to leading, late-stage venture-backed companies while aiming to deliver faster liquidity and mitigate downside risk for our limited partners.